StudyKIK Introduces Remote eConsent Technology Solution with Integrated Telemedicine Video Calling for Clinical Trials

Share Article

In the rapidly changing clinical trial industry due to COVID-19, StudyKIK has released a eConsent technology with built-in telemedicine video capabilities to allow sites and participants all the tools needed to sign consent remotely.

News Image
This solution also allows for a personalized connection via video between site and participant so they can easily review a consent document...

StudyKIK, a full service patient recruitment & retention technology company headquartered in Irvine, CA announced today the release of their fully remote eConsent platform with Telemedicine Video Calling technology. Now, any sponsor who has provided their enrolling sites access to StudyKIK’s recruitment technology can choose to access their eConsent with instant video calling capabilities as well. Given the current climate in clinical research, StudyKIK’s newest eConsent technology allows clinical trials to progress while ensuring ease of consent to both participants and research facilities. This innovative technology solution is offered globally and is currently being implemented on multiple crucial clinical trials.

Matt Miller, StudyKIK’s President/ CEO said
“Providing technology and services to enhance both site operations and the trial participant’s experience has been our focus since day one. With the release of our newest eConsent with Telemedicine Video Calling technology, we can easily add this platform to any of our existing 3,600+ research site portals - providing a safe and secure way for people to consent into clinical trials. This solution also allows for a personalized connection via video between site and participant so they can easily review a consent document together to ensure quality and understanding.”

The new StudyKIK eConsent with Telemedicine Video Calling technology can be used across multiple use cases including, language variations, visual impairments, hearing impairments, Consent and Assent, re-consents, and multiple video callers at once. This completely integrated technology also works across nearly all devices without the need to download cumbersome applications, allowing for the highest level of adoption from site and clinical trial participants.

Sponsors who select to use StudyKIK’s eConsent & Telemedicine Video Calling solution have access to real-time blinded consent data in the same StudyKIK management platform used for recruitment and retention; thus cutting down on the need to juggle multiple data sources and logins. This solution can be used together with existing StudyKIK services or as a standalone service.

StudyKIK is continuing to build technologies which are accessible to research sites from a single login in order to make clinical trial operations as streamlined as possible. StudyKIK’s new eConsent with Telemedicine Video Calling is another step in fulfilling this mission and accelerating the overall recruitment process.

More About StudyKIK:
StudyKIK is a full service patient recruitment and retention company that leverages technology, social media patient communities, and indication-specific expertise to ensure study timelines and sponsor budgets are met. Since its inception, StudyKIK has reached over 6 million patients and connected over 3.1 million patients to studies.

StudyKIK provides recruitment and retention technology solutions for patients, sites, CROs, and sponsors as well as customized app technology to assist with patient retention once patients are randomized. As a result, StudyKIK is the global leader in patient recruitment and retention strategy and implementation.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Matt Miller
StudyKIK
+1 (877) 627-2509
Email >
Visit website